Video

The Importance of Diverse Clinical Trials in Cancer

Author(s):

Donna Cryer, CEO and president of the Global Liver Institute, discusses the importance of having diverse clinical trials in cancer care.

Donna Cryer, CEO and president of the Global Liver Institute, discusses the importance of having diverse clinical trials in cancer care.

While patients may not often be aware of clinical trials, it might be the best treatment option for many of them. It is crucial that these patients talk to other patients who were on clinical trials, as well as their health care providers to better understand the process and become more comfortable with them.

Also, it is crucial that minorities and people around the world of different ethnic backgrounds participate in clinical trials so that when a therapy is approved, its efficacy has been proven for a variety of different genetic makeups.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of doctor.
Image of man with black hair.
Picture of Dr. Pouneh Razavi
Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Image of Crispino
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Anne M. Reb is a nurse practitioner with City of Hope.